278 related articles for article (PubMed ID: 18536608)
1. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
French DD; Margo CE
Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
[TBL] [Abstract][Full Text] [Related]
2. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
Fraunfelder FW; Winthrop K; Suhler E; Choi D; Fraunfelder FT
Retina; 2009 Feb; 29(2):285-6; author reply 286-7. PubMed ID: 19202428
[No Abstract] [Full Text] [Related]
3. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration.
French DD; Margo CE
Cornea; 2007 Oct; 26(9):1087-9. PubMed ID: 17893540
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates: uveitis and scleritis.
Prescrire Int; 2013 May; 22(138):128. PubMed ID: 23819179
[No Abstract] [Full Text] [Related]
5. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study.
Etminan M; Forooghian F; Maberley D
CMAJ; 2012 May; 184(8):E431-4. PubMed ID: 22470169
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation in fracture patients treated with oral bisphosphonates.
Abrahamsen B; Eiken P; Brixen K
J Intern Med; 2009 May; 265(5):581-92. PubMed ID: 19141097
[TBL] [Abstract][Full Text] [Related]
7. Bilateral uveitis secondary to bisphosphonate therapy.
Tan YL; Sims J; Chee SP
Ophthalmologica; 2009; 223(3):215-6. PubMed ID: 19221448
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonate-associated scleritis: a case report and review.
Leung S; Ashar BH; Miller RG
South Med J; 2005 Jul; 98(7):733-5. PubMed ID: 16108245
[TBL] [Abstract][Full Text] [Related]
9. Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study.
French DD; Margo CE
Retina; 2010 Feb; 30(2):271-4. PubMed ID: 20010456
[TBL] [Abstract][Full Text] [Related]
10. A pilot study to describe antidepressant prescriptions dispensed to veterans after stroke.
Ried LD; Tueth MJ; Jia H
Res Social Adm Pharm; 2006 Mar; 2(1):96-109. PubMed ID: 17138503
[TBL] [Abstract][Full Text] [Related]
11. Nodular scleritis following alendronate therapy.
Tabbara KF
Ocul Immunol Inflamm; 2008; 16(3):99-101. PubMed ID: 18569796
[TBL] [Abstract][Full Text] [Related]
12. Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest.
Suhler EB; Lloyd MJ; Choi D; Rosenbaum JT; Austin DF
Am J Ophthalmol; 2008 Dec; 146(6):890-6.e8. PubMed ID: 19027424
[TBL] [Abstract][Full Text] [Related]
13. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population.
Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J
Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) as a research tool for identification of patients with uveitis and scleritis.
Uchiyama E; Faez S; Nasir H; Unizony SH; Plenge R; Papaliodis GN; Sobrin L
Ophthalmic Epidemiol; 2015 Apr; 22(2):139-41. PubMed ID: 25777314
[TBL] [Abstract][Full Text] [Related]
15. Corneal graft rejection precipitated by uveitis secondary to alendronate sodium therapy.
Richards JC; Wiffen SJ
Cornea; 2006 Oct; 25(9):1100-1. PubMed ID: 17133063
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral bisphosphonate therapy on serum calcium in elderly veterans with poor kidney function.
Vouri SM; Alvarez CA; Blaszczyk AT
Am J Geriatr Pharmacother; 2012 Jun; 10(3):178-84. PubMed ID: 22542895
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
Pazianas M; Clark EM; Eiken PA; Brixen K; Abrahamsen B
J Bone Miner Res; 2013 Mar; 28(3):455-63. PubMed ID: 23044864
[TBL] [Abstract][Full Text] [Related]
18. [Bisphosphonate-induced ocular and orbital inflammation].
Jakobsen TS; Funding M
Ugeskr Laeger; 2022 Jul; 184(28):. PubMed ID: 35959811
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of a large cohort of patients with scleritis and episcleritis.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):43-50. PubMed ID: 21963265
[TBL] [Abstract][Full Text] [Related]
20. Leflunomide use during the first 33 months after food and drug administration approval: experience with a national cohort of 3,325 patients.
Siva C; Eisen SA; Shepherd R; Cunningham F; Fang MA; Finch W; Salisbury D; Singh JA; Stern R; Zarabadi SA
Arthritis Rheum; 2003 Dec; 49(6):745-51. PubMed ID: 14673959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
